Skip to main content
. 2014 May 9;8(1):351–354. doi: 10.3892/ol.2014.2131

Figure 2.

Figure 2

Kaplan-Meier estimates of the OS time of paclitaxel combined with capecitabine (PX) as first-line chemotherapy for advanced or recurrent gastric cancer. The median OS time was 12.0 months (95% CI, 9.8–14.1 months). OS, overall survival; CI, confidence interval.